Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes.

Leukemia - 1 May 2017

Guidugli L, Johnson A K, Alkorta-Aranburu G, Nelakuditi V, Arndt K, Churpek J E, Godley L A, Townsley D, Young N S, Fitzpatrick C, Del Gaudio D, Das S, Li Z

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Aged, 80 and over
Share to Child, Preschool
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infant

Share to Leukemia

Share to Myelodysplastic Syndromes

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 28104920
DOI: 10.1038/leu.2017.28
PMCID: PMC5420790

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes.PMID 28104920Read ↗

Genetic Testing in the Myelodysplastic Syndromes: Molecular Insights Into Hematologic DiversitySemantic proximity Read ↗

Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement.Semantic proximity Read ↗

Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromesSemantic proximity Read ↗

Practical considerations for diagnosis and management of patients and carriers.Semantic proximity Read ↗

Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?Semantic proximity Read ↗

[Molecular profiling of myelodysplastic syndromes].Semantic proximity Read ↗

Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia DiagnosticsSemantic proximity Read ↗

[NGS-based multi-gene panel testing in hematological malignancies: therapeutic significance].Semantic proximity Read ↗

The Impact of Somatic and Germline Mutations in Myelodysplastic Syndromes and Related Disorders.Semantic proximity Read ↗

Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.Semantic proximity Read ↗

Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey.Semantic proximity Read ↗

The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practiceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.